NS · Pharmaceuticals

Windlas Biotech Ltd (WINDLAS)

Pharmaceuticals & Biotechnology

Windlas Biotech Ltd (WINDLAS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $18.05B, P/E ratio is 27.16, net margin is 8.0%, dividend yield is 0.68%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for WINDLAS

Market cap

$18.05B

P/E ratio

27.16

Net margin

8.0%

Dividend yield

0.68%

Windlas Biotech Ltd (WINDLAS) — FAQ

What is Windlas Biotech Ltd's market cap?

Windlas Biotech Ltd (WINDLAS) has a reported market cap of $18.05B (data as of 2026-07-10).

What is WINDLAS's P/E ratio?

The price-to-earnings (P/E) ratio for Windlas Biotech Ltd (WINDLAS) is 27.16 (data as of 2026-07-10).

Does Windlas Biotech Ltd pay a dividend?

Windlas Biotech Ltd (WINDLAS) shows a reported dividend yield of 0.68%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Windlas Biotech Ltd in?

Windlas Biotech Ltd (WINDLAS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).

What exchange is WINDLAS listed on?

WINDLAS is listed on NS.

What is Windlas Biotech Ltd's net margin?

Windlas Biotech Ltd (WINDLAS) reports a net margin of 8.0% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Pharmaceuticals companies

FDC Ltd (FDC) Strides Pharma Science Ltd (STAR)